Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: 10x Genomics Inc., 3 years.
10x Genomics Inc.
Director
Parabilis Medicines Inc.
Director · President & CEO
Chief executive roles
Parabilis Medicines Inc.
· President & CEO
Since June 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2024 | 10x Genomics Inc. | Grant or award | +8,649 | — | — |
| Jun 14, 2023 | 10x Genomics Inc. | Grant or award | +1,865 | — | — |
| May 11, 2023 | 10x Genomics Inc. | Option exercise | +200,000 | $1.16 | $232,000 |
| May 11, 2023 | 10x Genomics Inc. | Open-market sale | −33,000 | $52.82 | $1,743,060 |
Questions about Mathai Mammen
What boards is Mathai Mammen on?
Mathai Mammen sits on the boards of 10x Genomics Inc. and Parabilis Medicines Inc.
What company is Mathai Mammen the CEO of?
Mathai Mammen has been President & CEO of Parabilis Medicines Inc. since June 2026.
How long has Mathai Mammen served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.